Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Somatic HLA mutations expose the role of class I–mediated autoimmunity in aplastic anemia and its clonal complications

    ... thought to be driven by human leukocyte antigen ( HLA )–restricted T cell immunity, with earlier studies favoring HLA class II-mediated pathways. Using whole-exome sequencing (WES), we recently ...

    Research Article last updated 10/23/2017 - 10:56am.

  2. HLA-Matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft-versus-Host Disease, and Overall Survival.

    ... The HLA class II DRB1 antigen DR15 (common alleles *1501, *1502) is an ... aplastic anemia (SAA). We studied 1204 recipients of HLA-matched sibling bone marrow transplantation for SAA to determine ...

    Research Article last updated 06/15/2012 - 2:55pm.

  3. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.

    ... commonly involved the human leukocyte antigen ( HLA ) locus, leading to loss of one HLA haplotype. Loss of HLA-A expression from multiple lineages of leukocytes ...

    Research Article last updated 10/12/2011 - 3:13pm.

  4. Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

    ... (HSCT) from Human Leukocyte Antigen ( HLA )-mismatched related donors for children and young adults with ... Available related donor who is mismatched at ≥ 2 HLA alleles Exclusion Criteria:  Available HLA -identical related donor HIV positive Active uncontrolled ...

    Clinical Trial last updated 04/29/2016 - 10:59am.

  5. Current outcome of HLA identical sibling vs. unrelated donor transplants in severe aplastic anemia: an EBMT analysis

    Journal Title:  Haematologica Primary Author:  Bacigalupo A Author(s):  Bacig...

    Research Article last updated 03/02/2015 - 12:38pm.

  6. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia

    Journal Title:  Pediatr Blood Cancer Primary Author:  McGuinn C Author(s):  M...

    Research Article last updated 04/09/2014 - 9:11am.

  7. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ... risk index (DRI)-matched patient age ≥ 65 undergoing HLA -matched unrelated donor (MUD) HCT for AML or MDS during the ...

    Research Article last updated 11/14/2017 - 10:09am.

  8. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia

    ... We retrospectively analyzed the impact of HLA mismatching (HLA-A, -B, -C, -DRB1, -DQB1) using molecular typing on transplant outcome for ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Repurposing older drugs to help prevent GVHD

    ... to receive myeloablative HCT from an available 8/8- HLA matched URD. Patients received GVHD prophylaxis with tacrolimus and ...

    Article last updated 10/18/2017 - 8:48am.

  10. Haploidentical transplant in patients with myelodysplastic syndrome

    ... risk and the type of donor. In patients without an HLA -matched sibling donor, a family haploidentical donor is an alternative ... A total of 228 patients transplanted from a mismatched HLA-related donor between 2007 and 2014 were studied. The median age at ...

    Research Article last updated 10/04/2017 - 9:19am.